2014
DOI: 10.1371/journal.pone.0094680
|View full text |Cite
|
Sign up to set email alerts
|

Pregnancy in Obese Mice Protects Selectively against Visceral Adiposity and Is Associated with Increased Adipocyte Estrogen Signalling

Abstract: Maternal obesity is linked with increased adverse pregnancy outcomes for both mother and child. The metabolic impact of excessive fat within the context of pregnancy is not fully understood. We used a mouse model of high fat (HF) feeding to induce maternal obesity to identify adipose tissue-mediated mechanisms driving metabolic dysfunction in pregnant and non-pregnant obese mice. As expected, chronic HF-feeding for 12 weeks preceding pregnancy increased peripheral (subcutaneous) and visceral (mesenteric) fat m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
18
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(22 citation statements)
references
References 34 publications
4
18
0
Order By: Relevance
“…Glucose concentrations during pregnancy were a predictor of adverse obstetric outcome independent from obesity as previously reported [ 42 ], but were not associated with Caesarean section rates reflecting the importance of other factors in determining Caesarean sections. Our evidence that pregnancy has more profound metabolic effects on lean women concord with previous human [ 43 ] and rodent studies, where excess glucose intolerance in a high-fat-fed group in early pregnancy was not present by late pregnancy [ 44 ] as well as other animal studies [ 45 ].…”
Section: Discussionsupporting
confidence: 90%
“…Glucose concentrations during pregnancy were a predictor of adverse obstetric outcome independent from obesity as previously reported [ 42 ], but were not associated with Caesarean section rates reflecting the importance of other factors in determining Caesarean sections. Our evidence that pregnancy has more profound metabolic effects on lean women concord with previous human [ 43 ] and rodent studies, where excess glucose intolerance in a high-fat-fed group in early pregnancy was not present by late pregnancy [ 44 ] as well as other animal studies [ 45 ].…”
Section: Discussionsupporting
confidence: 90%
“…Such an activity of secreted WISP2 has been reported [ 48 ] and is also consistent with the increase in WISP2 expression observed as fat deposition rates decline in the older WxH and PxH genotype animals (Figure 1 E). However, direct inhibition of IMF synthesis in HGP-treated animals could also be explained by estrogen signalling, ERalpha agonists have been shown to inhibit de novo lipogenesis in vitro [ 53 ] and estradiol treatment has been shown to decrease lipogenesis and TAG storage in vivo [ 54 ]. Clearly further investigation of the mechanism of the suppression of lipid deposition in cattle LM by HGP is required.…”
Section: Resultsmentioning
confidence: 99%
“…We have previously suggested that one explanation might be maternal adaptations which occurred during pregnancy, so that although prior to conception, DIO dams were heavier and hyperglycaemic and hyperinsulinaemic when compared to control dams, they gained less weight and were no longer hyperglycaemic or hyperlipidaemic in late gestation [9,25]. Finally, although other studies report effects are present in F1 offspring by 6 months, it is possible that a phenotype might become more apparent in our model with ageing [26].…”
Section: Discussionmentioning
confidence: 99%